학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 91건 | 목록 1~20
Academic Journal
Hurvitz SA; Fred Hutchinson Cancer Center, University of Washington, Seattle, USA.; Loi S; Peter MacCallum Cancer Centre, Melbourne, Australia.; O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, USA.; Okines AFC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Tolaney SM; Dana-Farber Cancer Institute, Boston, USA.; Sohn J; Yonsei Cancer Center, Seoul, South Korea.; Saura C; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Zhu X; Cross Cancer Institute, University of Alberta, Edmonton, Canada.; Cameron D; Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.; Bachelot T; Centre Léon Bérard, Lyon, France.; Hamilton E; Sarah Cannon Research Institute, Nashville, USA.; Curigliano G; European Institute of Oncology, Milan, Italy; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Wolff AC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, USA.; Harbeck N; Breast Center, Department of OB&GYN and CCC Munich, LMU University Hospital, Munich, Germany.; Masuda N; Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Vahdat L; Dartmouth Health, Lebanon, USA.; Zaman K; Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Valdes-Albini F; Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables.; Block M; Nebraska Cancer Specialists, Omaha, USA.; Pluard T; Saint Luke's Cancer Institute, Kansas City, USA.; Tan TJ; National Cancer Centre Singapore, Singapore.; Gawryletz C; University of Colorado Health, Fort Collins, USA.; Chan A; Breast Cancer Research Centre, Nedlands, Australia; Curtin University, Perth, Australia.; Bedard PL; Princess Margaret Hospital, University Health Network, Toronto, Canada.; Yerushalmi R; Rabin Medical Center, Petah Tikva, Israel; Tel Aviv University, Tel Aviv, Israel.; Xu B; Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China.; Schmitt M; Pfizer Inc., Bothell, USA.; Xie D; Pfizer Inc., Bothell, USA.; Borges VF; University of Colorado Cancer Center, Aurora, USA. Electronic address: virginia.borges@cuanschutz.edu.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Toss A; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Blondeaux E; Clinical Trial Unit, U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Tenedini E; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Bonamici L; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Graffeo R; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Livraghi L; Nuovo Ospedale di Prato-Santo Stefano, Prato, Italy.; Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, Monterrey, Mexico.; Bernstein Molho R; Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, affiliated to Tel Aviv University, Tel Hashomer, Israel.; Kwong A; Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong SAR; Cancer Genetics Centre and Breast Surgery Centre, Hong Kong Sanatorium and Hospital, Hong Kong SAR; Department of Surgery, The University of Hong Kong, Hong Kong SAR.; Balmana J; Hereditary Cancer Genetics Unit, Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven.; Agostinetto E; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Service de Oncologie, Brussels, Belgium.; Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Renaud T; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France.; Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Center, Lyon, France; Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France; INSERM U1290 RESHAPE, Lyon, France.; Ferrari A; Hereditary Breast and Ovarian Cancer (HBOC) Unit and General Surgery 3-Senology, Breast Cancer Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; University of Pavia, Pavia, Italy.; Moore HCF; Department of Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, USA.; Peccatori FA; Gynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, Italy.; Paluch-Shimon S; Sharett Institute of Oncology, Hadassah University Hospital & Faculty of Medicine, Hebrew University, Jerusalem, Israel.; Fruscio R; UO Gynecology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.; Micheri C; SUMA (Grupo Cooperativo Argentino para el Estudio y la Investigación del Cáncer de Mama), Buenos Aires, Argentina.; Wong SM; Stroll Cancer Prevention Centre, Jewish General Hospital, and McGill University Medical School, Montreal, Canada.; Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Vernieri C; Breast Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Lee MK; Memorial Sloan Kettering Cancer Center MSKCC, New York, USA.; De Marchis L; Division of Medical Oncology, Department of Radiological, Oncological and Pathological Sciences, 'La Sapienza' University of Rome, Rome, Italy; Oncology Unit, Department of Hematology Oncology and Dermatology, Umberto 1 Policlinico di Roma, Rome, Italy.; Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, USA.; Del Mastro L; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Avano (CRO) IRCCS, Aviano, Italy; Department of Medicine, University of Udine, Udine, Italy.; Meireles PA; Medical Oncology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.; Kemp Z; Breast Medical Oncology and Cancer Genetics Units, Royal Marsden Hospital, London, UK.; Matikas A; Department of Oncology/Pathology, Karolinska Institute and Breast Center, Karolinska University Hospital, Stockholm, Sweden.; Plichta J; Department of Surgery, Duke University, Durham, USA.; Del Pilar Estevez-Diz M; Department of Medical Oncology, Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.; Di Meglio A; Université Paris-Saclay, Gustave Roussy, Inserm, Prédicteurs moléculaires et nouvelles cibles en oncologie, F-94805, Villejuif, France.; Cichowska-Cwalinska N; Medical University of Gdansk, Gdansk, Poland.; Gianni C; Medical Oncology, Breast & GYN Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Yerushalmi R; Davidoff Cancer Center, Rabin Medical Center-Beilinson, Petah Tikva, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sanchez-Bayona R; Hospital Universitario 12 de Octubre, Madrid, Spain.; Mrinakova B; Department of Oncology, Faculty of Medicine, Comenius University and St. Elisabeth Cancer Institute Bratislava, Slovakia.; Matos L; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.; Bianchini G; IRCCS Ospedale San Raffaele, Milan, Italy.; Caleffi M; Nucleo Mama, Hospital Moinhos de Vento, Porto Alegre, Brazil.; Krivokuca A; Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.; Abdou Y; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, USA.; Mariño-Mariño M; Hospital Universitario Son Espases, Palma, Spain.; Parokonnaya A; Blokhin National Medical Research Center of Oncology, Moscow, Russia.; Okano M; Hoshi General Hospital, Koriyama, Japan; Fukushima Medical University, Fukushima, Japan.; Antone N; Institute of Oncology 'Ion Chiricuta', Cluj-Napoca, Romania.; Saavedra C; Ramon y Cajal, IOB Institute of Oncology (Madrid), International Breast Cancer Center (IBCC), Madrid, Spain.; Sonnenblick A; The Oncology Division, Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Duchnowska R; Department of Oncology, Military institute of Medicine-National Research Institute, Warsaw, Poland.; Pais HL; Hospital de Santa Maria-University of Lisbon, Lisbon, Portugal.; Harbeck N; Breast Center, Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany.; Cortesi L; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy; AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy.; Delucchi V; Clinical Trial Unit, U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; De Angelis C; Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples; Istituto Nazionale Tumori Napoli IRCCS 'Fondazione Pascale', Naples, Italy.; Lambertini M; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. Electronic address: matteo.lambertini@unige.it.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Goetz MP; Department of Oncology, Mayo Clinic, Rochester. Electronic address: goetz.matthew@mayo.edu.; Bagegni NA; Division of Oncology, Washington University School of Medicine, St. Louis, USA.; Batist G; Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.; Brufsky A; University of Pittsburgh Medical Center-Magee Women's Hospital, Pittsburgh.; Cristofanilli MA; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York.; Damodaran S; The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston.; Daniel BR; Tennessee Oncology, Chattanooga.; Fleming GF; The University of Chicago Medical Center, Chicago.; Gradishar WJ; Division of Hematology/Oncology, Northwestern University, Chicago.; Graff SL; Lifespan Cancer Institute/Legorreta Cancer Center at Brown University, Providence.; Grosse Perdekamp MT; Carle Cancer Center, Carle Foundation Hospital, Urbana.; Hamilton E; Sarah Cannon Research Institute/Tennessee Oncology, Nashville.; Lavasani S; Division of Hematology and Medical Oncology, UC Irvine, Orange.; Moreno-Aspitia A; Division of Hematology/Oncology, Mayo Clinic, Jacksonville.; O'Connor T; Roswell Park Comprehensive Cancer Center, Department of Medicine, Buffalo.; Pluard TJ; Saint Luke's Cancer Institute, Kansas City.; Rugo HS; Department of Medicine (Hematology/Oncology), University of California San Francisco, San Francisco.; Sammons SL; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Schwartzberg LS; Pennington Cancer Institute, University of Nevada, Reno.; Stover DG; Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus.; Vidal GA; Breast Oncology Division, West Cancer Center, Memphis.; Wang G; Medical Oncology, Miami Cancer Institute at Baptist Health, Miami, USA.; Warner E; Division of Medical Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Yerushalmi R; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Tel-Aviv University, Tel-Aviv, Israel.; Plourde PV; Sermonix Pharmaceuticals, Columbus, USA.; Portman DJ; Sermonix Pharmaceuticals, Columbus, USA.; Gal-Yam EN; Breast Oncology Institute, Sheba Medical Center, Ramat Gan, Israel.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Geyer CE Jr; NRG Oncology/NSABP Foundation, Pittsburgh; Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh.; Garber JE; Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Gelber RD; Dana-Farber Cancer Institute, Harvard Medical School, Boston; Harvard T.H. Chan School of Public Health, Boston; Frontier Science Foundation, Boston.; Yothers G; NRG Oncology/NSABP Foundation, Pittsburgh; Department of Biostatistics, University of Pittsburgh, Pittsburgh, USA.; Taboada M; Oncology Biometrics Department, AstraZeneca, Macclesfield.; Ross L; Department of Data Management, Frontier Science (Scotland), Kincraig, Scotland, UK.; Rastogi P; NRG Oncology/NSABP Foundation, Pittsburgh; Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh.; Cui K; Department of Oncology R&D, AstraZeneca, Gaithersburg, USA.; Arahmani A; Research Operations Department, Breast International Group, Brussels, Belgium.; Aktan G; Global Oncology Clinical Development, Merck and Co. Inc., Rahway, USA.; Armstrong AC; Department of Medical Oncology, The Christie Hospital NHS Foundation Trust Manchester, UK.; Arnedos M; European Organisation for Research and Treatment (EORTC), Brussels, Belgium; The Department of Medical Oncology, Institut Bergonie, Bordeaux, France.; Balmaña J; Medical Oncology Department, Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona, Spain.; Bergh J; Department of Oncology-Pathology, Swedish Breast Cancer Group, Karolinska Institute and Breast Cancer Center, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.; Bliss J; Department of Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK.; Delaloge S; Department of Cancer Medicine, Institute Gustave Roussy and Unicancer Breast Group, Paris, France.; Domchek SM; Department of Medicine, Basser Center for BRCA at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.; Eisen A; Odette Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada.; Elsafy F; Oncology Biometrics Department, AstraZeneca, Macclesfield.; Fein LE; Department of Clinical Research, Instituto de Oncologia De Rosario, Santa Fe, Argentina.; Fielding A; Department of Oncology R&D, AstraZeneca, Gaithersburg, USA.; Ford JM; Department of Medicine/Oncology, Stanford University School of Medicine, Stanford.; Friedman S; Facing Our Risk of Cancer Empowered, Tampa, USA.; Gelmon KA; Department of Medical Oncology, BC Cancer, Vancouver, Canada.; Gianni L; Department of Oncology, International Breast Cancer Study Group, Bern, Switzerland; Department of Medical Oncology, Ospedale Infermi AUSL della Romagna, Rimini, Italy.; Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Hollingsworth SJ; Department of Late Development Oncology, AstraZeneca, Cambridge, UK.; Im SA; Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.; Jager A; Department of Medical Oncology, Dutch Breast Cancer Research Group, Utrecht, the Netherlands.; Jóhannsson ÓÞ; Department of Medical Oncology, Landspítali University Hospital of Iceland, Icelandic Breast Cancer Group, Reykjavik, Iceland.; Lakhani SR; Department of Anatomical Pathology, The University of Queensland Centre for Clinical Research and Pathology Queensland, Brisbane, Australia.; Janni W; Department for Obstetrics and Gynecology, Universitaetsklinikum, University of Ulm, Ulm, Germany.; Linderholm B; Department of Oncology, Sahlgrenska University Hospital, Gothenburg; Department of Oncology, The Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.; Liu TW; Division of Cancer Research, National Health Research Institutes, Taiwan Cooperative Oncology Group, Taipei City, Taiwan.; Loman N; Department of Hematology, Oncology, and Radiation Physics, Swedish Association of Breast Oncologists, Skåne University Hospital, Lund, Sweden.; Korde L; Clinical Investigations Branch, Division of Cancer Treatment and Diagnosis, The National Cancer Institute, Rockville, USA.; Loibl S; Medicine and Research, German Breast Group, Neu-Isenburg; Medicine and Research, The Center for Hematology and Oncology Bethanien and Goethe University, Frankfurt, Germany.; Lucas PC; NRG Oncology/NSABP Foundation, Pittsburgh; Department of Pathology, UPMC Hillman Cancer Center, Pittsburgh, USA.; Marmé F; Medical Faculty Mannheim, Heidelberg University, Mannheim Germany and the German Breast Group, Neu-Isenburg, Germany.; Martinez de Dueñas E; Médica Consorcio Hospitalario Provincial de Castellón, Servicio de Oncología, Castellón, Spain.; McConnell R; Department of Data Management, Frontier Science (Scotland), Kincraig, Scotland, UK.; Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne; Breast Cancer Trials, Australia and New Zealand, Newcastle, Australia.; Piccart M; Department of Scientific Direction, Institut Jules Bordet, l'Université Libre de Bruxelles, Brussels.; Rossi G; Department of Research and Development, Breast International Group, Brussels, Belgium.; Schmutzler R; The Center for Familial Breast and Ovarian Cancer and the Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.; Shao Z; Fudan University Shanghai Cancer Center, Shanghai, China.; Sharma P; Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, USA.; Singer CF; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Španić T; Department of Patient Advocacy, Europa Donna-The European Breast Cancer Coalition, Milan, Italy; Europa Donna Slovenia, Ljubljana, Slovenia.; Stickeler E; Department of Obstetrics and Gynecology, University Hospital Aachen, Aachen, Germany.; Toi M; Department of Breast Surgery Kyoto University Hospital, Kyoto, Japan.; Traina TA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.; Viale G; Department of Pathology, University of Milan, European Institute of Oncology IRCCS, Milan.; Zoppoli G; Internal Medicine Oncology Unit, Gruppo Oncologico Italiano di Ricerca Clinica, Parma; Università degli Studi di Genova and IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Park YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Yerushalmi R; Department of Oncology, Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petach Tikva; Faculty of Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Yang H; Department of Breast Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou.; Pang D; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.; Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Mailliez A; Department of Medical Oncology, Breast Cancer Unit, Oscar Lambret Center, Lillie, France.; Fan Z; Department of Breast Surgery, First Hospital of Jilin University, Jilin, China.; Tennevet I; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France.; Zhang J; Breast Cancer Center, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.; Nagy T; Chemotherapy Department B, Országos Onkológiai Intézet, National Institute of Oncology, Budapest, Hungary.; Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Sun Q; Department of Breast Surgery, Peking Union Medical College Hospital, Peking, China.; Parton M; Breast Unit, Royal Marsden Hospital, London, UK.; Colleoni MA; Division of Medical Senology, European Institute of Oncology (IEO), IRCCS, Milan.; Schmidt M; Department of Obstetrics and Gynecology, University Medical Center Mainz, Mainz, Germany.; Brufsky AM; NRG Oncology/NSABP Foundation, Pittsburgh; Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh.; Razaq W; Department of Internal Medicine, Section of Hematology/Oncology, Oklahoma University Health, Oklahoma City, USA.; Kaufman B; The Breast Oncology Institute, Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.; Cameron D; Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh.; Campbell C; Department of Statistics and Programming, Frontier Science (Scotland), Kincraig, Scotland.; Tutt ANJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London; The Breast Cancer Now Unit, Guy's Hospital Cancer Centre, King's College London, London, UK. Electronic address: andrew.tutt@icr.ac.uk.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Al-Bustami H; Applied Physics Department and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem 91904, Israel.; Khaldi S; Institute of Chemistry and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Givat Ram Jerusalem 91904, Israel.; Shoseyov O; Applied Physics Department and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem 91904, Israel.; Yochelis S; Applied Physics Department and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem 91904, Israel.; Killi K; Institute of Chemistry and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Givat Ram Jerusalem 91904, Israel.; Berg I; Institute of Chemistry and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Givat Ram Jerusalem 91904, Israel.; Gross E; Institute of Chemistry and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Givat Ram Jerusalem 91904, Israel.; Paltiel Y; Applied Physics Department and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem 91904, Israel.; Yerushalmi R; Institute of Chemistry and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Givat Ram Jerusalem 91904, Israel.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 101088070 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-6992 (Electronic) Linking ISSN: 15306984 NLM ISO Abbreviation: Nano Lett Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Goldvaser H; a Institute of Oncology , Davidoff Center, Rabin Medical Center , Petach Tikva , Isarel.; e Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.; Rozen-Zvi B; b Department of Nephrology , Rabin Medical Center , Petah-Tikva , Israel.; e Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.; Yerushalmi R; a Institute of Oncology , Davidoff Center, Rabin Medical Center , Petach Tikva , Isarel.; e Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.; Gafter-Gvili A; c Medicine A , Beilinson Hospital, Rabin Medical Center , Petach Tikva , Israel.; d Institute of Hematology , Davidoff Center, Rabin Medical Center , Petach Tikva , Israel.; e Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.; Lahav M; d Institute of Hematology , Davidoff Center, Rabin Medical Center , Petach Tikva , Israel.; e Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.; Shepshelovich D; c Medicine A , Beilinson Hospital, Rabin Medical Center , Petach Tikva , Israel.; e Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.
Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE
Academic Journal
Lewin R; Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, 39 Jabotinski St., Petach Tikva, 49100, Israel. ronle1@clalit.org.il.; Sulkes A; Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, 39 Jabotinski St., Petach Tikva, 49100, Israel.; Shochat T; Statistical Consulting Unit, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel.; Tsoref D; Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, 39 Jabotinski St., Petach Tikva, 49100, Israel.; Rizel S; Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, 39 Jabotinski St., Petach Tikva, 49100, Israel.; Liebermann N; Clalit Health Services Headquarters, Tel-Aviv, Israel.; Hendler D; Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, 39 Jabotinski St., Petach Tikva, 49100, Israel.; Neiman V; Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, 39 Jabotinski St., Petach Tikva, 49100, Israel.; Ben-Aharon I; Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, 39 Jabotinski St., Petach Tikva, 49100, Israel.; Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel.; Paluch-Shimon S; Breast Cancer Service for Young Women, Oncology Institute, Sheba Medical Center, Tel-Hashomer, Israel.; Margel D; Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, 39 Jabotinski St., Petach Tikva, 49100, Israel.; Kedar I; Raphael Recanati Genetic Institute, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel.; Yerushalmi R; Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, 39 Jabotinski St., Petach Tikva, 49100, Israel.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Editorial & Opinion
Publisher: Israel Medical Association Country of Publication: Israel NLM ID: 100930740 Publication Model: Print Cited Medium: Internet ISSN: 1565-1088 (Print) NLM ISO Abbreviation: Isr Med Assoc J Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Yerushalmi, R
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어